Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Viemed Healthcare Q3 revenue rises, but slightly misses estimates

Viemed Healthcare Q3 revenue rises, but slightly misses estimates

ReutersReuters2026/11/04 22:22


Overview

  • US home-based healthcare provider's Q3 revenue grew 12% yr/yr, slightly missing analyst expectations

  • Company raised low end of full-year revenue guidance and narrowed adjusted EBITDA outlook


Outlook

  • Viemed expects 2026 revenue between $316 mln and $320 mln

  • Company narrows 2026 Adjusted EBITDA outlook to $64 mln-$66 mln

  • Net capital expenditures for 2026 now seen at 8.0%-9.0% of revenue


Result Drivers

  • VENTILATOR PATIENT VOLUME - Co said higher average patient volumes drove growth in ventilator rental revenue

  • PAP AND SLEEP RESUPPLY - Co reported strong growth in PAP therapy and sleep resupply patient counts

  • OPERATING LEVERAGE - Co attributed improved profitability to operating leverage and efficiency gains from earlier investments


Company press release: ID:nACS3NfVCa


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Slight Miss*

$80.67 mln

$80.78 mln (3 Analysts)

Q3 Net Income Attributable to Shareholders

$4.64 mln

Q3 Gross Profit

$46.19 mln

Q3 Income from Operations

$6.96 mln

*Applies to a deviation of less than 1%; not applicable for per-share numbers.


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the healthcare facilities & services peer group is "buy"

  • Wall Street's median 12-month price target for Viemed Healthcare Inc is $12.50, about 32.2% above its November 3 closing price of $9.46

  • The stock recently traded at 18 times the next 12-month earnings vs. a P/E of 21 three months ago


Reuters Recommended Reads

  • Nov 3 - Addus HomeCare Q3 adjusted EPS beats estimates; to acquire AccentCare personal care division

  • Nov 3 - Senior care provider InnovAge's Q1 revenue beats as participants increase

  • Nov 3 - AdaptHealth posts Q3 loss due to goodwill impairment charge


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss